Legal: Page 5
-
Medtech industry relieved as Europe’s MDR extension nears final approval
While the extra time to comply is aimed at preventing medical device shortages, the rules have still left some device makers and certifying bodies unclear about how to proceed, says one attorney.
By Susan Kelly • March 6, 2023 -
AliveCor says enforcement of Apple Watch import ban may take more than a year
The Biden administration upheld findings that Apple violated AliveCor’s patents, but a potential import ban rests on the outcome of a separate appeal, which could take several months.
By Elise Reuter • Feb. 22, 2023 -
J&J loses bid for Supreme Court review of $302M vaginal-mesh verdict
The justices’ decision to let a lower court verdict stand leaves the company subject to varying state liability laws, J&J says.
By Peter Green • Feb. 21, 2023 -
Applied Medical suit against Medtronic alleges surgical-device bundling practice curbs competition
Applied says in its filing that Medtronic “has conspired” to bundle devices for cutting tissue and sealing vessels “in a way that is unhealthy for competition.”
By Nick Paul Taylor • Updated Feb. 16, 2023 -
Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device
Alcon is settling the case for far less than the $3.1 billion that J&J’s damages expert argued the company could be owed.
By Nick Paul Taylor • Feb. 14, 2023 -
Medtronic ordered by jury to pay $106.5M to Colibri over TAVR patent infringement
Medtronic says the ruling will have no effect on its TAVR business as the patents expired last year and it vowed to appeal the verdict.
By Nick Paul Taylor • Updated Feb. 14, 2023 -
Invacare files for Chapter 11 bankruptcy protection amid supply chain woes
The wheelchair maker said it has reached a restructuring agreement with most of its debt holders and that demand for its products remains strong.
By Susan Kelly • Updated Feb. 3, 2023 -
FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine
Regulators said they are putting the industry on watch with the enforcement against GoodRx, which allegedly collected data, including patient medications, and shared it without user consent.
By Rebecca Pifer • Updated Feb. 1, 2023 -
Apple Watch infringed on Masimo patent, judge rules, raising prospect of import ban
Masimo’s CEO said the ruling “exposes Apple as a company that takes other companies’ innovations and repackages them.”
By Nick Paul Taylor • Updated Jan. 12, 2023 -
Sterigenics reaches $408M ethylene oxide settlement to resolve hundreds of lawsuits in Illinois
Sterigenics said “years of biased media coverage in the greater Chicago area” underpinned its decision to settle.
By Nick Paul Taylor • Jan. 11, 2023 -
Apple infringed on AliveCor wearable patents, ITC says in final ruling; import ban suspended
The commission found that Apple has infringed on two AliveCor patents and thereby violated a law that can trigger an import ban.
By Nick Paul Taylor • Jan. 4, 2023 -
Philips’ studies argue recalled DreamStation CPAP machines unlikely to harm patients’ health
In a briefing on testing of the machines, Philips said exposure to degraded foam used to soundproof the devices is unlikely to harm patients.
By Elise Reuter • Dec. 21, 2022 -
J&J subsidiaries accuse former Auris employees of stealing robotic surgery trade secrets
The lawsuit claims former Auris employees engaged in “shameless, systematic and ongoing misappropriation of trade secrets.”
By Nick Paul Taylor • Dec. 19, 2022 -
Illumina defends Grail acquisition before FTC amid potential divestiture order in Europe
Acquiring Grail would let Illumina help bring cancer tests to market sooner, saving thousands of lives, the company argues.
By Elise Reuter • Dec. 15, 2022 -
Deep Dive
Apple locked in court battles with small medtech firms over allegations of stolen technology
AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.
By Elise Reuter , Nick Paul Taylor • Updated Dec. 13, 2022 -
Apple prevails in AliveCor patent dispute ahead of potential Watch import ban
Patent board ruled that all 30 claims are unpatentable because they are obvious in view of other patents.
By Nick Paul Taylor • Dec. 8, 2022 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022
To find more content, use the "Topics" in the menu above.